The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid

Canadian Journal of Cardiology

Volumn 26, Issue 9, 2010, Pages 489-496

  Rodriguez Leyva, Delfin ^a,b,c   Bassett, Chantal M C ^a,b   McCullough, Richelle ^a,b   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Lenin Hospital   (Cuba)

Author keywords

Cardiovascular disease; Fibre; Fish; Heart disease; Lignans; Nutrition; Polyunsaturated fatty acids

Indexed keywords

BLOOD CLOTTING FACTOR; C REACTIVE PROTEIN; CHOLESTEROL; LINOLENIC ACID; LINSEED OIL; LIPOPROTEIN A; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LINSEED; MORBIDITY; MORTALITY; NUTRITIONAL HEALTH; OUTCOME ASSESSMENT; REVIEW; SMOKING; STROKE;

EID: 78649315164     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70455-4     Document Type: Review

References (109)

1. World Health Organization. World Health Statistics 2008. 〈http://www.who.int/whosis/whostat/〉 (Accessed on February 9, 2009).
2. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
3. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.
4. Erkkilä AT, Lehto S, Pyorala K, Uusitupa MI. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003;78:65-71.
5. Lamotte M, Annemans L, Kawalec P, Zoellners Y. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz 2006;31(Suppl 3):74-82.
6. Harris WS. n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997;65(Suppl 5):1645S-54S.
7. Sanders TA, Oakley FR, Miller GJ, et al. Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arterioscler Thromb Vasc Biol 1997;17:3449-60.
8. Grimsgaard S, Bonaa KH, Hansen JB, et al. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997;66:649-59.
9. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304. (Pubitemid 34219443)
10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
11. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003;23:e20-e30.
12. Howe PR. Dietary fats and hypertension. Focus on fish oil. Ann N Y Acad Sci 1997;827:339-52.
13. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
14. Appel LJ, Miller ER III, Seidler AJ, et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
15. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006;83:1526S-35S.
16. Thiébaut AC, Chajès V, Gerber M, et al. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 2009;124:924-31.
17. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83(Suppl):1467S-76S.
18. Simopoulos AP. Human requirement for N-3 polyunsaturated fatty acids. Poult Sci 2000;79:961-70.
19. Francois CA, Connor SL, Bolewicz LC, Connor WE. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003;77:226-33.
20. Austria JA, Richard MN, Chahine MN, et al. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 2008;27;214-21.
21. Kuijsten A, Arts IC, van't Veer P, et al. The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed. J Nutr 2005;135:2812-6.
22. Indu M, Ghafoorunissa. N-3 fatty acids in Indian diets - comparison of the effects of precursor (alpha-linolenic acid) vs product (long chain n-3 polyunsaturated fatty acids). Nutr Res 1992;12:569-82.
23. Patenaude A, Rodriguez-Leyva D, Edel AL, et al. Bioavailability of alpha linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr 2009;63:1123-9.
24. Harper CR, Edwards MJ, DeFilipis AP, Jacobson TA. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 2006;136:83-7.
25. Burdge GC, Calder PC. Dietary α-linolenic acid and health-related outcomes: A metabolic perspective. Nutr Res Rev 2006;19:26-52.
26. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71(Suppl 1):179-88.
27. Whelan J, Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr 2006;26:75-103.
28. Hu FB, Stampfer MJ, Manson JE, et al. Dietary intake of α-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;69:890-7.
29. Albert CM, Oh K, Whang W, et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005;112:3232-8.
30. Baylin A, Kabagambe EK, Ascherio A, et al. Adipose tissue α-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation 2003;107:1586-91.
31. Oda E, Hatada K, Katoh K, et al. A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction. Int Heart J 2005;46:583-91.
32. Djoussé L, Arnett DK, Carr JJ, et al. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries. The NHLBI Family Heart Study. Circulation 2005;111:2921-6.
33. Djoussé L, Pankow JS, Eckfeldt JH, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2001;74:612-9.
34. Ascherio A, Rimm EB, Giovannucci EL, et al. Dietary fat and risk of coronary heart disease in men: Cohort follow up study in the United States. BMJ 1996;313:84-90.
35. Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 1992;200:177-82.
36. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
37. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction; the Indian experiment of infarct survival - 4. Cardiovasc Drugs Ther 1997;11:485-91.
38. Dupasquier CM, Weber AM, Ander BP, et al. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 2006;291:H2987-96.
39. Dupasquier CM, Dibrov E, Kostenuk AL, et al. Dietary flaxseed inhibits atherosclerosis in the LDL receptor deficient mouse in part through anti-proliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 2007;293:H2394-402.
40. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999;103:747-53.
41. Hirono S, Dibrov E, Hurtado C, et al. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ Res 2003;93:710-6.
42. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-22.
43. Thies F, Miles EA, Nebe-von-Caron G, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001;36:1183-93.
44. Rallidis LS, Paschos G, Liakos GK, et al. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003;167:237-42.
45. Rallidis LS, Paschos G, Papaioannou ML, et al. The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 2004;174:127-32.
46. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134:2991-7.
47. Djoussé L, Rautaharju PM, Hopkins PN, et al. Dietary linolenic acid and adjusted QT and JT intervals in the NHLBI Family Heart Study. J Am Coll Cardiol 2005;17;45:1716-22.
48. Ander BP, Weber AR, Rampersad PP, Gilchrist JS, Pierce GN, Lukas A. Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic rabbits. J Nutr 2004;134:3250-6.
49. Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001;85:321-41.
50. Antzelevitch C, Shimizu W, Yan GX, et al. Cellular basis for QT dispersion. J Electrocardiol 1998;30(Suppl):168-75.
51. 2+ exchanger to α-linolenic acid. Cardiovasc Res 2007;73:395-403.
52. Djoussé L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: The NHLBI Family Heart Study. Am J Clin Nutr 2003;77:819-25.
53. Seidelin KN, Jensen B, Haugaard SB, Reith J, Olsen TS. Ischemic stroke and n-3 fatty acids. J Stroke Cereb Dis 1997;6:405-9.
54. Simon JA, Fong J, Bernert JT Jr, Browner WS. Serum fatty acids and the risk of stroke. Stroke 1995;26:778-82.
55. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000;19:1784-93.
56. Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alphalinolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006;137:241-51.
57. Heurteaux C, Guy N, Laigle C, et al. TREK-1, a K(-)channel involved in neuroprotection and general anesthesia. EMBO J 2004;23:2684-95.
58. Nestel PJ, Pomeroy SE, Sasahara T, et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 1997;17:1163-70.
59. Cunnane SC, Hamadeh MJ, Liede AC, et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995;61:62-8.
60. Singer P, Berger I, Wirth M, Godicke W, Jaeger W, Voigt S. Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukot Med 1986;24:173-93.
61. Bloedon LT, Balikai S, Chittams J, et al. Flaxseed and cardiovascular risk factors: Results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 2008;27:65-74.
62. Stuglin C, Prasad K. Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 2005;10:23-7.
63. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002;100:495-504.
64. Clark WF, Kortas C, Heidenheim AP, et al. Flaxseed in lupus nephritis: A two-year nonplacebo-controlled crossover study. J Am Coll Nutr 2001;20:143-8.
65. Harper CR, Edwards MC, Jacobson TA. Flaxseed oil supplementation does not affect plasma lipoprotein concentration or particle size in human subjects. J Nutr 2006;136:2844-8.
66. Otvos JD, Collins D, Freedman DS, et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by Gemfibrozil therapy in the Veterans affairs high-density lipoprotein intervention trial. Circulation 2006;113:1556-63.
67. Patade A, Devareddy L, Lucas EA, Korlagunta K, Daggy BP, Arjmandi BH. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. J Womens Health (Larchmt) 2008;17:355-66.
68. Zhang W, Wang X, Liu Y, et al. Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 2008;99:1301-9.
69. Bloedon LT, Szapary PO. Flaxseed and cardiovascular risk. Nutr Rev 2004;62:18-27.
70. Arjmandi BH, Khan DA, Juma S. Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res 1998;18:1203-14.
71. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002;87:1527-32.
72. Djoussé L, Hunt SC, Arnett DK, et al. Dietary linolenic acid is inversely associated with plasma triacylglycerol: The NHLBI Family Heart Study. Am J Clin Nutr 2003;78:1098-102.
73. Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 2007;61:1201-6.
74. Wilde C. Hidden Causes of Heart Attack and Stroke: Inflammation. Cardiology's New Frontier. Studio City: Abigon Press, 2003:184-5.
75. Djoussé L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 2005;45:368-73.
76. Bemelmans WJ, Muskiet FA, Feskens EJ, et al. Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. Eur J Clin Nutr 2000;54:865-71.
77. Takeuchi H, Sakurai C, Noda R, et al. Antihypertensive effect and safety of dietary alpha-linolenic acid in subjects with high-normal blood pressure and mild hypertension. J Oleo Sci 2007;56:347-60.
78. Salonen JT, Salonen R, Ihanainen M, et al. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 1988;48:1226-32.
79. Rise P, Marangoni F, Galli C. Regulation of PUFA metabolism: Pharmacological and toxicological aspects. Prostaglandins Leukot Essent Fatty Acids 2002;67:85-9.
80. Agostoni C, Riva E, Giovannini M, et al. Maternal smoking habits are associated with differences in infants' long-chain polyunsaturated fatty acids in whole blood: A case-control study. Arch Dis Child 2008;93:414-8.
81. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas I, Stefanadis C. Five-year incidence of cardiovascular disease and its predictors in Greece: The ATTICA study. Vasc Med 2008;13:113-21.
82. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
83. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005;82:1178-84.
84. Hallund J, Tetens I, Bügel S, Tholstrup T, Bruun JM. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 2008;18:497-502.
85. Dodin S, Cunnane SC, Mâsse B, et al. Flaxseed on cardiovascular disease markers in healthy menopausal women: A randomized, double-blind, placebo-controlled trial. Nutrition 2008;24:23-30.
86. Nelson TL, Stevens JR, Hickey MS. Inflammatory markers are not altered by an eight week dietary α-linolenic acid intervention in healthy abdominally obese adult males and females. Cytokine 2007;38:101-6.
87. Faintuch J, Horie LM, Barbeiro HV, et al. Systemic inflammation in morbidly obese subjects: Response to oral supplementation with alpha-linolenic acid. Obes Surg 2007;17:341-7.
88. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 2008;6:1-8.
89. Djoussé L, Hunt SC, Tang W, Eckfeldt JH, Province MA, Ellison RC. Dietary linolenic acid and fasting glucose and insulin: The National Heart, Lung, and Blood Institute Family Heart Study. Obesity 2006;14:295-300.
90. Prasad K. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: Effect of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 2000;209:89-96.
91. Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 2001;138:32-9.
92. Pan A, Sun J, Chen Y, et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double-blind, cross-over trial. PLoS ONE 2007;2:e1-148.
93. Das UN. A defect in the activity of Δ6 and Δ5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids 2005;72:343-50.
94. Tao M, McDowell MA, Saydah SH, Eberhardt MS. Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care 2008;31:93-5.
95. Velasquez MT, Bhathena SJ, Ranich T, et al. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int 2003;64:2100-7.
96. Tohgi N. Effect of alpha-linolenic acid-containing linseed oil on coagulation in type 2 diabetes. Diabetes Care 2004;27:2563-4.
97. Kelly DS, Nelson JG, Love JE, et al. Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans. Lipids 1993;28:533-7.
98. Finnegan YE, Howarth D, Minihane AM, et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. J Nutr 2003;133:2210-3.
99. Freese R, Mutanen M. Linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am J Clin Nutr 1997;66:59l-8.
100. Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997;65:1687S-98S.
101. Allman MA, Pena NM, Pang D. Supplementation with flaxseed oil versus sunflower oil in healthy young men consuming a low fat diet: Effects on platelet composition and function. Eur J Clin Nutr 1995;49:169-78.
102. Akabas SR, Deckelbaum RJ. Summary of a workshop on n-3 fatty acids: Current status of recommendations and future directions. Am J Clin Nutr 2006;83(Suppl):1536S-8S.
103. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001;39:58-65.
104. Pruthi S, Thompson SL, Novotny PJ, et al. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integr Oncol 2007;5:106-12.
105. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Intern Med 2006;166:357-65.
106. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009;360:573-87.
107. Williams RB. Blood pressure reactivity to psychological stress: A new risk factor for coronary disease? Hypertension 2006;47:329-30.
108. Conklin SM, Harris JI, Manuck SB, Yao JK, Hibbeln JR, Muldoon MF. Serum w-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res 2007;152:1-10.
109. Spence JD, Thornton T, Muir AD, Westcott ND. The effect of flax seed cultivars with differing content of α-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr 2003;22:494-501.